A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes

Carcinogenesis

Volumn 26, Issue 12, 2005, Pages 2086-2094

  Gilot, David ^a,d   Serandour, Anne Laure ^b   Ilyin, Guennady P ^b   Lagadic Gossmann, Dominique ^a,d   Loyer, Pascal ^b   Corlu, Anne ^b   Coutant, Alexandre ^b   Baffet, Georges ^b   Peter, Marcus E ^c   Fardel, Olivier ^a,d   Guguen Guillouzo, Christiane ^b  

^a INSERM   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUTANT PROTEIN; OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; ENZYME ACTIVITY; GENETIC CODE; IMMUNOPRECIPITATION; LIVER CELL; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASES; CELL PROLIFERATION; CELLS, CULTURED; DNA REPLICATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; G1 PHASE; HEPATOCYTES; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE KINASE 1; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION;

EID: 27944454415     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi187     Document Type: Article

References (60)

1. Taub,R. (2004) Liver regeneration: From myth to mechanism. Nat. Rev. Mol. Cell. Biol., 5, 836-847.
2. Talarmin,H., Rescan,C., Cariou,S., Glaise,D., Zanninelli,G., Bilodeau,M., Loyer,P., Guguen-Guillouzo,C. and Baffet,G. (1999) The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol. Cell. Biol., 19, 6003-6011.
3. Rescan,C., Coutant,A., Talarmin,H., Theret,N., Glaise,D., Guguen-Guillouzo,C. and Baffet,G. (2001) Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol. Biol. Cell, 12, 725-738.
4. 1. J. Biol. Chem., 271, 11484-11492.
5. Danielsen,A.J. and Maihle,N.J. (2002) The EGF/ErbB receptor family and apoptosis. Growth Factors, 20, 1-15.
6. Jorissen,R.N., Walker,F., Pouliot,N., Garrett,T.P., Ward,C.W. and Burgess,A.W. (2003) Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp. Cell Res., 284, 31-53.
7. Wang,X., DeFrances,M.C., Dai,Y., Pediaditakis,P., Johnson,C., Bell,A.F. Michalopoulos,G.K. and Zarnegar,R. (2002) A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell, 9, 411-421.
8. Reinehr,R., Gorg,B., Hongen,A. and Haussinger,D. (2004) CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes. J. Biol. Chem., 279, 10364-10373.
9. Reinehr,R., Schliess,F. and Haussinger,D. (2003) Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. FASEB J., 17, 731-733.
10. Alderson,M.R., Armitage,R.J., Maraskovsky,E., Tough,T.W., Roux,E., Schooley,K., Ramsdell,F. and Lynch,D.H. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med., 178, 2231-2235.
11. Owen-Schaub,L.B., Meterissian,S. and Ford,R.J. (1993) Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J. Immunother., 14, 234-241.
12. Zhang,J., Cado,D., Chen,A., Kabra,N.H. and Winoto,A. (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature, 392, 296-300.
13. Hua,Z.C., Sohn,S.J., Kang,C., Cado,D. and Winoto,A. (2003) A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity, 18, 513-521.
14. Aggarwal,B.B., Singh,S., LaPushin,R. and Totpal,K. (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett., 364, 5-8.
15. Freiberg,R.A., Spencer,D.M., Choate,K.A., Duh,H.J., Schreiber,S.L., Crabtree,G.R. and Khavari,P.A. (1997) Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol., 108, 215-219.
16. Jelaska,A. and Korn,J.H. (1998) Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: Differences between foreskin and adult fibroblasts. J. Cell Physiol., 175, 19-29.
17. Kennedy,N.J., Kataoka,T., Tschopp,J. and Budd,R.C. (1999) Caspase activation is required for T cell proliferation. J. Exp. Med., 190, 1891-1896.
18. Chun,H.J., Zheng,L., Ahmad,M. et al. (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature, 419, 395-399.
19. Salmena,L., Lemmers,B., Hakem,A. et al. (2003) Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev., 17, 883-895.
20. Yeh,W.C., Itie,A., Elia,A.J. et al. (2000) Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity, 12, 633-642.
21. Tschopp,J., Irmler,M. and Thome,M. (1998) Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol., 10, 552-558.
22. Boatright,K.M., Deis,C., Denault,J.B., Sutherlin,D.P. and Salvesen,G.S. (2004) Activation of caspases-8 and -10 by FLIP(L). Biochem. J., 382, 651-657.
23. Micheau,O., Thome,M., Schneider,P., Holler,N., Tschopp,J., Nicholson,D.W., Briand,C. and Grutter,M.G. (2002) The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem., 277, 45162-45171.
24. Chang,D.W., Xing,Z., Pan,Y., Algeciras-Schimnich,A., Barnhart,B.C., Yaish-Ohad,S., Peter,M.E. and Yang,X. (2002) c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J., 21, 3704-3714.
25. Peter,M.E. (2004) The flip side of FLIP. Biochem. J., 382, e1-e3.
26. Yang,B.F., Xiao,C., Roa,W.H., Krammer,P.H. and Hao,C. (2003) Calcium/ calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J. Biol. Chem., 278, 7043-7050.
27. Guguen-Guillouzo (ed.) (2002) Isolation and Culture of Animals and Human Hepatocytes. John Wiley and Sons Inc., New York.
28. Stennicke,H.R. and Salvesen,G.S. (1997) Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem., 272, 25719-25723.
29. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
30. Ilyin,G.P., Glaise,D., Gilot,D., Baffet,G. and Guguen-Guillouzo,C. (2003) Regulation and role of P21 and P27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am. J. Physiol. Gastrointest. Liver Physiol., 19, 19.
31. Yeh,J.H., Hsu,S.C., Han,S.H. and Lai,M.Z. (1998) Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med., 188, 1795-1802.
32. Kataoka,T., Budd,R.C., Holler,N. et al. (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol., 10, 640-648.
33. Park,S.J., Kim,Y.Y., Ju,J.W., Han,B.G., Park,S.I. and Park,B.J. (2001) Alternative splicing variants of c-FLIP transduce the differential signal through the Raf or TRAF2 in TNF-induced cell proliferation. Biochem. Biophys. Res. Commun., 289, 1205-1210.
34. Okano,H., Shiraki,K., Inoue,H. et al. (2003) Cellular FLICE/ caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab. Invest., 83, 1033-1043.
35. Scaffidi,C., Schmitz,I., Krammer,P.H. and Peter,M.E. (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem., 274, 1541-1548.
36. Kataoka,T. and Tschopp,J. (2004) N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol. Cell. Biol., 24, 2627-36.
37. Tibbetts,M.D., Zheng,L. and Lenardo,M.J. (2003) The death effector domain protein family: Regulators of cellular homeostasis. Nat. Immunol., 4, 404-409.
38. Gilot,D., Miramon,M.L., Benvegnu,T., Ferrieres,V., Loreal,O., Guguen-Guillouzo,C., Plusquellec,D. and Loyer,P. (2002) Cationic lipids derived from glycine betaine promote efficient and non-toxic gene transfection in cultured hepatocytes. J. Gene Med., 4, 415-427.
39. Gilot,D., Loyer,P., Corlu,A., Glaise,D., Lagadic-Gossmann,D., Atfi,A., Morel,F., Ichijo,H. and Guguen-Guillouzo,C. (2002) Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S- transferase regulation. J. Biol. Chem., 277, 49220-49229.
40. Jones,R.A., Johnson,V.L., Buck,N.R., Dobrota,M., Hinton,R.H., Chow,S.C. and Kass,G.E. (1998) Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology, 27, 1632-1642.
41. Sasagawa,T., Hlaing,M. and Akaike,T. (2000) Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochem. Biophys. Res. Commun., 272, 674-680.
42. Inayat-Hussain,S.H., Couet,C., Cohen,G.M. and Cain,K. (1997) Processing/ activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes. Hepatology, 25, 1516-1526.
43. Micheau,O. (2003) Cellular FLICE-inhibitory protein: An attractive therapeutic target? Expert Opin. Ther. Targets, 7, 559-573.
44. Desbarats,J. and Newell,M.K. (2000) Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med., 6, 920-923.
45. Desbarats,J., Birge,R.B., Mimouni-Rongy,M., Weinstein,D.E., Palerme,J.S. and Newell,M.K. (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol., 5, 118-125.
46. Eymin,B., Sordet,O., Droin,N., Munsch,B., Haugg,M., Van de Craen,M., Vandenabeele,P. and Solary,E. (1999) Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene, 18, 4839-4847.
47. Fero,M.L., Rivkin,M., Tasch,M. et al. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85, 733-744.
48. Karnezis,A.N., Dorokhov,M., Grompe,M. and Zhu,L. (2001) Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J. Clin. Invest., 108, 383-390.
49. Thornberry,N.A., Rano,T.A., Peterson,E.P. et al. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem., 272, 17907-17911.
50. Han,Y., Giroux,A., Grimm,E.L. et al. (2004) Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors. Bioorg. Med. Chem. Lett., 14, 805-808.
51. Uhlmann,F., Wernic,D., Poupart,M.A., Koonin,E.V. and Nasmyth,K. (2000) Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell, 103, 375-386.
52. Uhlmann,F. (2003) Separase regulation during mitosis. Biochem. Soc. Symp., 243-251.
53. Chen,J., Fujii,K., Zhang,L., Roberts,T. and Fu,H. (2001) Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc. Natl Acad. Sci. USA, 98, 7783-7788.
54. Chong,H., Vikis,H.G. and Guan,K.L. (2003) Mechanisms of regulating the Raf kinase family. Cell Signal., 15, 463-469.
55. Thome,M., Schneider,P., Hofmann,K. et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature, 386, 517-521.
56. Shu,H.B., Halpin,D.R. and Goeddel,D.V. (1997) Casper is a FADD- and caspase-related inducer of apoptosis. Immunity, 6, 751-763.
57. Inohara,N., del Peso,L., Koseki,T., Chen,S. and Nunez,G. (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem., 273, 12296-12300.
58. Grambihler,A., Higuchi,H., Bronk,S.F. and Gores,G.J. (2003) cFLIP-L inhibits p38 MAPK activation: An additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J. Biol. Chem., 12, 12.
59. Chaudhary,P.M., Jasmin,A., Eby,M.T. and Hood,L. (1999) Modulation of the NF-kappa B pathway by vitally encoded death effector domains-containing proteins. Oncogene, 18, 5738-5746.
60. Siegmund,D., Hadwiger,P., Pfizenmaier,K., Vornlocher,H.P. and Wajant,H. (2002) Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis. Mol. Med., 8, 725-732.